Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disorder that affects
the connective tissues and has the highest mortality rate among the rheumatic diseases …

Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal disease for which therapeutic
options are limited, with an unmet need to identify new therapeutic targets. IPF is thought to …

The mechanisms underlying post-hemorrhagic hydrocephalus (PHH) development following
subarachnoid hemorrhage (SAH) are not fully understood, which complicates informed …

Matrix remodeling is a salient feature of idiopathic pulmonary fibrosis (IPF). Targeting cells
driving matrix remodeling could be a promising avenue for IPF treatment. Analysis of …

Pulmonary fibrosis represents the advanced phase of diverse pulmonary ailments, and at
present, a definitive cure for these ailments is lacking. Furthermore, underlying mechanisms …

Idiopathic pulmonary fibrosis (IPF) carries a high mortality rate and has a poor prognosis.
The pathogenesis of pulmonary fibrosis (PF) is highly related to dysregulation of multiple …

Idiopathic pulmonary fibrosis (IPF) is the most common and most severe form of pulmonary
fibrosis, a scarring disease of the lungs resulting in progressive lung stiffness and …

Interstitial lung diseases (ILDs) are a group of conditions in which pulmonary tissue is
affected by abnormal cellular processes including inflammation, fibrosis or a combination of …

Background: Past research has found that fibroblast growth factor 19 (FGF19) is associated
with several hepatic disorders, such as alcoholic liver disease and primary biliary cirrhosis …

As key actors in embryogenesis and organogenesis, fibroblast growth factors (FGFs) can
assume a protective or an aggravative role in pulmonary fibrosis pathophysiology. Among …